Market Cap: $28.57B
Market Cap: $28.57B
Open
$216.31
Prev. Close
$256.35
High
$216.52
Low
$213.00
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing.
Quest Diagnostics Incorporated trades on the New York Stock Exchange under the ticker DGX, priced in USD.
Quest Diagnostics Incorporated has a market capitalisation of $28.57B, based on its latest share price.
DGX trades at 25.20 times its trailing 12-month earnings.
Over the past 52 weeks DGX has traded between $171.18 and $263.19.
Yes. Quest Diagnostics Incorporated's dividend yields 1.32% at the current share price, paying out 33% of its earnings.
Profitable, with a net margin of 9.5% over the last 12 months.
The analyst consensus rating for DGX is Hold. Analysts' average 12-month price target of $235.67 implies 9% downside.
James E. Davis is the CEO of Quest Diagnostics Incorporated, which is headquartered in Secaucus.
Generated automatically from reported financial data. General information only, not financial advice.

Quest Diagnostics (Ticker: DGX) marks a significant milestone in oncology diagnostics with the recent approval of its Haystack MRD liquid biopsy test. The New York State Department of Health's Clinica…

Quest Diagnostics significantly enhances its drug screening capabilities to meet evolving regulatory demands and capitalize on market opportunities. Innovative Drug Screening Enhancements The company…
Transforming AI Workflows in Diagnostics: Quali's Integration with NVIDIA In the fast-evolving landscape of artificial intelligence and healthcare diagnostics, the integration of Quali's Torque platfo…
Quest Diagnostics Leverages AI Workflows Through Strategic Collaborations In recent developments within the healthcare diagnostics sector, Quest Diagnostics stands at the forefront of integrating adva…